Voacamine

CAS No. 3371-85-5

Voacamine( Voacanginine )

Catalog No. M24284 CAS No. 3371-85-5

Voacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 263 In Stock
10MG 448 In Stock
25MG 721 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Voacamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Voacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity.
  • Description
    Voacamine is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity. Voacamine also inhibits P-glycoprotein (P-gp) action in multidrug-resistant tumor cells.Voacanginine may have rhythmic effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Voacanginine
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    CB1|P-gp
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3371-85-5
  • Formula Weight
    704.91
  • Molecular Formula
    C43H52N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C(C1(C(C(C2)CC)N3CC2C1)C4=C(CC3)C(C=C(OC)C([C@H](CC(/C(CN5C)=C/C)C(C(OC)=O)[C@H]5C6)C7=C6C(C=CC=C8)=C8N7)=C9)=C9N4)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Condello M , Pellegrini E , Multari G , et al. Voacamine: Alkaloid with its essential dimeric units to reverse tumor multidrug resistance[J]. Toxicology in Vitro, 2020, 65:104819.
molnova catalog
related products
  • 2,3-Butanediol

    2,3-Butanediol is a butanediol derived from the bioconversion of natural resources which has great potential for diverse industries, including chemical, cosmetics, agriculture, and pharmaceutical areas.

  • AEF0117

    AEF0117, a signaling-specific inhibitor of cannabinoid receptor 1 (CB1-SSi), inhibits cannabinoid self-administration and behavioral disorders associated with THC, and can be used to study cannabis withdrawal.

  • XL-001

    XL-001 (XL001) is a novel specific CB2 inverse agonist with Ki of 0.5 nM.